Drug Design & Medicinal Chemistry Congress01 - 02 June 2021 | London, UK
Bringing you the latest in enabling technologies, computational-based drug design and discovery chemistry. Key focus areas include: DNA-encoded libraries, protein-to-protein interactions, AI/ML in drug design, and medicinal chemistry for oncology
Drug Design and Medicinal Chemistry Congress includes...
Join over 400 leaders, experts and scientists at this event, helping to shape the future of discovery chemistry and computational drug design:
Learn about key focus areas include DNA encoded libraries, protein-protein interactions, AI/ML in drug design and new modalities such as Protein Degradation and Covalent Inhibitors.
Gain successful strategies in compound library development, DNA/RNA encoded libraries, protein to protein interaction, fragment and structured based drug design
Focusing on cutting edge tools, including: AI in ADME, big data management, model management, artificial intelligence, machine learning in drug design and AI in chemical synthesis, AI-enabled target ID capabilities, lead identification/optimisation
Engage in interactive discussions on the Integration Of DEL, Covalent Inhibitors and Protein Degradation Technologies In The Optimization Of HITs.
Agenda at a Glance
Stream 4: Computational Drug Design: AI Focus
Afternoon Interactive Roundtable Sessions:
- Addressing Difficult Targets with New Novel Approaches in Drug Design
- AI in Drug Design – Where Are We?
- Digitising Drug Discovery Labs
- AI & Data Analysis
Workshop: Deploying 3D Modelling To Chemists
Stream 3: Integration Of Technologies In The Optimization Of HITs – DEL, Covalent Inhibitors and Protein Degradation
Stream 4: Molecular Drug Design and Medicinal Chemistry
Interactive Roundtable Discussions:
- New Chemical Modalities and Challenging Targets: (Small and Large Molecules) and Choice of Modalities
- Covalent Inhibitors Design and Discovery – Overcoming Challenges